There is a well-known set of published figures on what regular cycling is associated with at the level of a population. They come from health impact assessments that put three things on the same scale: the mortality reduction associated with the physical activity, the mortality increase associated with breathing more polluted air while exercising near traffic, and the mortality increase associated with being on a bicycle in traffic at all. This calculator reproduces that arithmetic transparently, using the published numbers as editable inputs.
It is important to be clear about what the output is. It is a population-level association reported by an observational study, scaled by an assumption you choose. It is not a prediction about your own lifespan, and association is not causation: people who cycle regularly differ from people who do not in many ways that no study fully adjusts for. Arb Digital builds these tools to make published research checkable, not to make claims about anyone's health.
What This Biking Life Gain Calculator Does
It takes a published estimate of life expectancy gained from regular cycling, subtracts the published estimates of life expectancy lost to traffic risk and to air pollution exposure, and reports the net figure as a range. It then scales that range if your weekly cycling exposure differs from the exposure the published scenario describes.
The defaults come from the study by de Hartog and colleagues, "Do the Health Benefits of Cycling Outweigh the Risks?", published in Environmental Health Perspectives in 2010. For people shifting from car to bicycle for short urban trips in the Netherlands, that paper reports 3 to 14 months of life gained through increased physical activity, 0.8 to 40 days lost to increased inhaled air pollution, and 5 to 9 days lost to traffic accidents. Its stated conclusion is that the beneficial effects of the increased physical activity are substantially larger than the mortality risks from the other two.
Every one of those numbers is an input here, not a hard-coded constant, so you can put a different study's figures in and see what they produce.
How to Use It
- Decide what scenario you are modelling. The default figures describe a specific change: routine short car trips replaced by bicycle trips, in one country, over a long period. If that is not your situation, the numbers do not transfer cleanly.
- Set the reference weekly hours to the exposure the published scenario represents in whatever source you are reading, and your own weekly hours beside it. Leave them equal to see the published range unmodified.
- Choose a scaling assumption. Linear is the simplest and overstates the effect at high exposures. Square root crudely reflects the flattening seen in published dose-response curves and is not itself a published relation. Neither is a substitute for a study of your exposure level.
- Read the range, not the midpoint. The gap between 3 and 14 months is the honest uncertainty in the source. Reporting a single number from it would misrepresent the research.
- Treat the result as a description of a population. It is not a forecast, and it does not apply to any individual.
The Formula and How It Is Calculated
Let Glo and Ghi be the published gain bounds in months, Dlo and Dhi the summed deduction bounds in days, and s the exposure scaling factor. Converting months to days at 30.4375 days per month, the net range is:
netlo = s × Glo × 30.4375 − s × Dhi and nethi = s × Ghi × 30.4375 − s × Dlo
The lower bound of the net pairs the smallest gain with the largest deductions, and the upper bound pairs the largest gain with the smallest, which is the conservative way to combine two independent ranges.
Worked through with the loaded values and no scaling: the lower gain of 3 months is 3 × 30.4375 = 91.31 days, and the upper of 14 months is 426.13 days. The deductions sum to 5 + 0.8 = 5.8 days at the low end and 9 + 40 = 49 days at the high end. So the net range is 91.31 − 49 = 42.31 days at the bottom and 426.13 − 5.8 = 420.33 days at the top, or roughly 1.4 to 13.8 months. That reproduces the paper's own conclusion: the benefit term dominates across the whole range.
Why This Is an Association and Not a Prediction
The studies underlying these figures are observational cohort studies. They follow large groups of people over years, record who cycles and who does not, and compare mortality rates. What they can establish is that the cycling group had lower mortality after adjusting for the confounders the researchers measured. What they cannot establish is that cycling caused the difference for any particular person.
The reason is that people who cycle regularly are not a random sample. They tend to differ in income, in other physical activity, in smoking, in diet, in occupation, and in baseline health — and crucially in whether they were healthy enough to cycle in the first place. That last one is called reverse causation and it is the hardest to remove: people who are already unwell are less likely to cycle, which makes cycling look protective even where it is not. Good studies adjust for what they can measure and exclude early deaths to reduce it, and the residual is still there.
Large cohort work has continued to find the association. The UK Biobank analysis published in the BMJ in 2017 by Celis-Morales and colleagues reported lower all-cause and cardiovascular mortality among cycle commuters compared with non-active commuters in a cohort of over a quarter of a million people. It is consistent, well-conducted observational evidence, and it is still observational evidence.
The Three Terms Do Not Transfer Between Countries
This is the limitation that most often gets ignored when these figures are quoted. All three terms are country-specific and two of them dramatically so.
The traffic risk term depends on cycling infrastructure, driver behaviour, cycling rates and the legal environment. Cyclist fatality rates per kilometre travelled differ by close to an order of magnitude between countries with mature separated cycling networks and countries without them, so a deduction derived in the Netherlands is not a deduction that applies elsewhere. The air pollution term depends on ambient concentrations, on how close the cycling route runs to traffic, and on ventilation rate while riding, all of which vary enormously by city and by route choice.
The benefit term travels better, because the physiological association between physical activity and mortality is observed across many populations, but even it depends on what the cycling replaced. Replacing a car journey adds activity; replacing a walk or a run may not. If you are adapting these numbers to somewhere other than the study population, the honest approach is to substitute local figures for all three inputs, which is why they are all editable here.
What the Number Cannot Tell You
It cannot tell you anything about your own life expectancy. Individual lifespan is dominated by genetics, existing conditions, accidents and chance, and a population-average shift of a few months says nothing about where any one person falls. It also says nothing about quality of life, which is where much of the actual argument for cycling lives and which mortality studies do not measure at all.
It does not account for your route, your equipment, whether you ride in traffic or on separated paths, or the time of day you ride, all of which affect both risk terms substantially. It does not account for age: the physical activity association and the traffic risk both vary with age, and combining them at a population average hides that.
And it should not be read as advice. If you have a cardiac, respiratory or musculoskeletal condition, or you are returning to exercise after a break or an illness, that is a conversation with a clinician who knows your history, not something a calculator can address. Our MET minutes calculator reports published activity volume against the published guidelines as what those guidelines say, and the life expectancy calculator is a separate general estimator built on different inputs entirely; neither is a health assessment.
Using It Alongside the Practical Cycling Tools
Weekly cycling hours is the input this page needs and the one people are least sure about. If you know your distances rather than your times, the cycling pace calculator converts between them, and the cycling calorie calculator gives the published energy expenditure for a ride. For the commuting scenario the default figures describe, the car vs bike calculator works out the cost, time and emissions side of the same swap.
Used together those pages describe the change in concrete terms — distance, time, money, emissions — which are things a calculator can state without qualification. The life-expectancy figure is the one that needs all the caveats on this page attached to it every time it is quoted.
Arb Digital builds free calculators like this one as search-visible entry points, then turns the traffic they earn into audience and enquiries with content and technical SEO built around the terms your readers actually type.
Content Marketing Talk to Arb DigitalCommon Mistakes to Avoid
- Quoting a single number from the range. The published estimate spans 3 to 14 months for a reason. Collapsing it to a midpoint hides the uncertainty the researchers reported.
- Reading it as a personal forecast. It is a population average from observational data. No individual experiences an average, and nothing here predicts one person's lifespan.
- Treating association as causation. People who cycle differ from people who do not in many measured and unmeasured ways, including how healthy they were to begin with.
- Transferring the risk terms between countries. Traffic risk and air pollution deductions are specific to the roads and air of the study population and can differ by an order of magnitude elsewhere.
- Scaling linearly to very high exposures. The published dose-response flattens. Extrapolating a linear gain to twenty hours a week produces a number no study supports.
Related Free Tools From Arb Digital
For the practical side of the same journeys, the car vs bike calculator compares cost, time and emissions, and the cycling pace calculator and cycling power calculator cover speed, time and effort. The cycling calorie calculator and MET minutes calculator report published energy and activity-volume figures, and the life expectancy calculator is a separate general estimator built from age and lifestyle inputs rather than from a cycling study. Browse the free online tools hub for the rest.
Frequently Asked Questions
Published observational studies report an association between regular cycling and lower all-cause mortality at the population level. Association is not causation, and no study of this kind can establish that cycling will extend any particular person's life.
From de Hartog and colleagues, "Do the Health Benefits of Cycling Outweigh the Risks?", published in Environmental Health Perspectives in 2010. For a shift from car to bicycle for short trips in the Netherlands it reports 3 to 14 months gained through physical activity, 0.8 to 40 days lost to air pollution and 5 to 9 days lost to traffic accidents.
No. It is a population-level association scaled by an assumption you choose. Individual lifespan is dominated by genetics, existing conditions and chance, and nothing on this page applies to one person.
In the source study they do not. The physical activity gain is measured in months and the two deductions in days, and the paper's stated conclusion is that the benefit is substantially larger. That balance is specific to the population studied and could differ where roads or air quality differ.
Not directly. Cyclist fatality rates per kilometre and ambient air pollution both vary enormously between countries, so both deduction terms are country-specific. All the inputs on this page are editable so local figures can be substituted.
Because the published relationship between physical activity and mortality is not linear: most of the association is between doing nothing and doing a little, and it flattens after that. Square-root scaling is a crude way to reflect that flattening, and it is not itself a published relation.
The published dose-response curves flatten at higher volumes, so the marginal association shrinks. Extrapolating a linear gain to very high weekly hours produces a figure no study supports.
That is not a question a calculator can answer. This page reproduces published research arithmetic. Decisions about exercise, particularly with an existing cardiac, respiratory or musculoskeletal condition, belong with a clinician who knows your history.
This calculator reproduces figures from published observational research for information only and is not medical advice. The result is a population-level association reported with wide uncertainty, not a prediction about any individual's lifespan, and association does not establish causation. The risk terms are specific to the population and country studied. Anyone with a cardiac, respiratory or musculoskeletal condition, or returning to exercise after illness or a long break, should speak to a physician or other qualified clinician.
